Login
Velsera blog - insights on the future of precision medicine
BLOG

Discussing the future of precision medicine.

Navigating your molecular lab’s test selection and development over the next two years

Navigating your molecular lab’s test selection and development over the next two years

With the FDA’s publication of the final rule on laboratory developed tests (LDTs) on May 6, 2024, clinical molecular laboratories are beginning to chart a course through the next five years. As described in the rule and in our first post of this seri...
go to article
Four Years, Five Stages: the FDA's Final Rule on LDTs

Four Years, Five Stages: the FDA's Final Rule on LDTs

After over a decade-long saga, the Food and Drug Administration (FDA) published its final rule on La...
go to article
Velsera_blog

Meeting the NIH Data Management and Sharing (DMS) policy requirements

The Velsera suite of NIH-funded platforms including Cancer Genomics Cloud (CGC), BioData Catalyst Po...
go to article
Velsera_blog

Highly Customizable Multi-sample Single Cell RNA-Seq Pipeline on CGC

The reasons and rationale behind single-cell RNA-Seq “To study human biology, we must know our cells...
go to article
load more